Sulpiride

Sulpiride (Dogmatil)

Chemical structure of Sulpiride.

Overview

Sulpiride, marketed under the brand name Dogmatil among others, is a medication identified as an atypical antipsychotic medication, though it has been classified by some sources as a typical antipsychotic. It belongs to the benzamide class of drugs and is primarily used to manage symptoms associated with psychosis in schizophrenia and major depressive disorder. In lower doses, Sulpiride can also be utilized to treat anxiety and mild forms of depression. The drug sees widespread use across various regions, including Asia, Central America, Europe, South Africa, and South America. Its purified levo-isomer, Levosulpiride, is marketed in India for similar therapeutic uses. Notably, Sulpiride is not authorized for use in the United States, Canada, or Australia. It shares chemical and clinical similarities with amisulpride.

Mechanism of action of antipsychotic drugs.

Medical Uses

Sulpiride is primarily indicated for the treatment of schizophrenia and major depressive disorder, where it functions by mitigating psychosis and depressive symptoms. For conditions such as anxiety and mild depression, Sulpiride is prescribed at lower dosages to take advantage of its sedative and antidepressant properties.

Pharmacology

Mechanism of Action

As a member of the benzamide class, Sulpiride exerts its therapeutic effects primarily through antagonism of the D2 dopamine receptors, which are implicated in the pathophysiology of psychosis and mood disorders. This action helps to normalize dopamine activity in the brain, thereby reducing psychotic symptoms and improving mood.

Pharmacokinetics

Details on the absorption, distribution, metabolism, and excretion of Sulpiride provide insights into its pharmacokinetic profile, which influences dosing schedules and potential drug interactions.

Side Effects

Sulpiride, like other antipsychotic medications, can cause a range of side effects. These may include, but are not limited to, extrapyramidal symptoms (EPS), tardive dyskinesia, weight gain, and sedation. Monitoring for side effects is an important aspect of treatment with Sulpiride.

Availability

While Sulpiride is available in various parts of the world, including Asia, Europe, and South America, it is not approved for use in countries like the United States, Canada, and Australia. The availability in different regions reflects the drug's regulatory approval status and clinical utility across diverse healthcare systems.

See Also

• Atypical antipsychotic
• Schizophrenia
• Major depressive disorder
• Levosulpiride
• Amisulpride

References

• World Health Organization (WHO)
• National Center for Biotechnology Information (NCBI)

External Links

• Sulpiride on Drugs.com
• Psychopharmacology Institute